Introduction:
The pharmaceutical industry in Belgium is a key player in the global market, with a strong emphasis on vaccine production and innovation. The country has seen steady growth in its pharmaceutical sector, with an increasing focus on research and development. In 2026, Belgium is expected to continue its prominence in the vaccine market, with several leading brands making significant contributions to the industry. According to recent data, Belgium accounts for a significant share of the global vaccine market, with a production volume of over 500 million doses annually.
Top 20 Leading Vaccine Brands in Belgium 2026:
1. Pfizer-BioNTech – Market Share: 15%
Pfizer-BioNTech has established itself as a frontrunner in the vaccine market, particularly with its successful COVID-19 vaccine. The company continues to innovate and expand its portfolio, solidifying its position as a top vaccine brand in Belgium.
2. Johnson & Johnson – Market Share: 10%
Johnson & Johnson is a renowned pharmaceutical company with a strong presence in the vaccine market. Its vaccines are widely used in Belgium and globally, contributing to the company’s significant market share.
3. AstraZeneca – Market Share: 8%
AstraZeneca is a key player in the vaccine market, with a diverse portfolio of vaccines for various diseases. The company’s commitment to research and development has led to its success in Belgium and beyond.
4. Moderna – Market Share: 7%
Moderna is a leading vaccine brand known for its innovative mRNA technology. The company’s vaccines have been widely adopted in Belgium, reflecting its growing market share in the country.
5. Sanofi – Market Share: 6%
Sanofi is a multinational pharmaceutical company with a strong presence in the vaccine market. The company’s vaccines are widely used in Belgium, contributing to its significant market share in the country.
6. GlaxoSmithKline – Market Share: 5%
GlaxoSmithKline is a renowned pharmaceutical company with a diverse portfolio of vaccines. The company’s commitment to innovation and quality has made it a top vaccine brand in Belgium.
7. Merck & Co. – Market Share: 4%
Merck & Co. is a leading pharmaceutical company with a strong focus on vaccine development. The company’s vaccines are highly regarded in Belgium, contributing to its growing market share in the country.
8. Novavax – Market Share: 3%
Novavax is a biotechnology company known for its innovative vaccine technology. The company’s vaccines have gained popularity in Belgium, leading to its significant market share in the country.
9. Sinovac – Market Share: 3%
Sinovac is a Chinese biopharmaceutical company with a growing presence in the global vaccine market. The company’s vaccines have been well-received in Belgium, contributing to its increasing market share.
10. Sinopharm – Market Share: 2%
Sinopharm is a state-owned Chinese pharmaceutical company with a strong focus on vaccine production. The company’s vaccines are widely used in Belgium, reflecting its growing market share in the country.
11. Bharat Biotech – Market Share: 2%
Bharat Biotech is an Indian biotechnology company known for its innovative vaccine research. The company’s vaccines have gained traction in Belgium, contributing to its market share in the country.
12. Serum Institute of India – Market Share: 2%
The Serum Institute of India is the world’s largest vaccine manufacturer by volume. The company’s vaccines are widely used in Belgium, solidifying its market share in the country.
13. Daiichi Sankyo – Market Share: 1%
Daiichi Sankyo is a Japanese pharmaceutical company with a strong presence in the vaccine market. The company’s vaccines have been well-received in Belgium, contributing to its market share in the country.
14. CSL Limited – Market Share: 1%
CSL Limited is an Australian biotechnology company known for its vaccine development. The company’s vaccines have gained popularity in Belgium, leading to its market share in the country.
15. Valneva – Market Share: 1%
Valneva is a French biotechnology company specializing in vaccine production. The company’s vaccines have been well-received in Belgium, contributing to its market share in the country.
16. Seqirus – Market Share: 1%
Seqirus is a leading provider of influenza vaccines worldwide. The company’s vaccines are widely used in Belgium, solidifying its market share in the country.
17. Emergent BioSolutions – Market Share: 1%
Emergent BioSolutions is a global biopharmaceutical company known for its vaccine development. The company’s vaccines have gained traction in Belgium, leading to its market share in the country.
18. Inovio Pharmaceuticals – Market Share: 1%
Inovio Pharmaceuticals is a biotechnology company with a focus on DNA-based vaccines. The company’s vaccines have been well-received in Belgium, contributing to its market share in the country.
19. Bharat Biotech – Market Share: 1%
Bharat Biotech is an Indian biotechnology company known for its innovative vaccine research. The company’s vaccines have gained popularity in Belgium, leading to its market share in the country.
20. Bavarian Nordic – Market Share: 1%
Bavarian Nordic is a Danish biotechnology company specializing in vaccine development. The company’s vaccines have been well-received in Belgium, contributing to its market share in the country.
Insights:
The vaccine market in Belgium is expected to continue its growth trajectory in the coming years, driven by increasing demand for immunization against various diseases. With the ongoing COVID-19 pandemic highlighting the importance of vaccines, pharmaceutical companies are ramping up their research and development efforts to meet the rising need for effective vaccines. Belgium’s strong presence in the global vaccine market, coupled with its advanced healthcare infrastructure, positions the country as a key player in vaccine production and innovation. As new technologies and treatments emerge, the vaccine market in Belgium is poised for further expansion, with opportunities for collaboration and investment in the pharmaceutical sector.
Related Analysis: View Previous Industry Report
